Price (delayed)
$0.3288
Market cap
$4.75M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.58
Enterprise value
$532,143
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
There are no recent dividends present for AEMD.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.